Preclinical Evaluation of the Efficacy, Pharmacokinetics and Immunogenicity of JS-001, a Programmed Cell Death Protein-1 (PD-1) Monoclonal Antibody

Acta Pharmacologica Sinica - United Kingdom
doi 10.1038/aps.2016.161

Related search